AUPH
Aurinia Pharmaceuticals Inc
3.07%
$8.48 - $8.74
Feb 8th 2023 - Mar 22nd 2023
Mar, 22, 2023
For a one product company, we sure have a lot of p... See more
Mar, 17, 2023
The Board will still keep PG, especially as we see sales increase
Jan, 18, 2023
$AVXL moving up in jumps: no shares for sale.
Jan, 17, 2023
SALES ARE COMING, no need to dilute anymore!
Dec, 9, 2022
$AVXL I love it when a $100 stock is on sale for $8.
Nov, 30, 2022
The list of indications will keep Making sales climb. .
Nov, 25, 2022
Lock your sales with high orders next week will be a lot of fun.
Mar, 22, 2023
For a one product company, we sure have a lot of people feeding off of it; think management, the board, the fantastic sales team.
Mar, 17, 2023
The Board will still keep PG, especially as we see sales increase
Mar, 17, 2023
$AUPH sales ramping up nicely here!
Mar, 16, 2023
Sales improving, patent safe, patent extension 2037, increase in insurance covering.
Mar, 13, 2023
$AUPH this company has everything to be set for a nice sale.
Mar, 10, 2023
Much better sale today.
Mar, 10, 2023
Blockbuster drug with improving sales and long patent life
Mar, 8, 2023
It will give time for SP to rise organically, higher sales, and higher BO.
Mar, 8, 2023
So, if we also get 1st continuation to be approved, sales are ramping ⬆️ up, then BO is going to be huge this year!!! !
Mar, 8, 2023
Growing revenue: AUPH's revenue has been growing steadily in recent years, driven by the increasing sales of Lupkynis.